http://www.anikatherapeutics.com
Anika Therapeutics, Inc. Company Intro
Anika Therapeutics is recognized worldwide as a pioneer in hyaluronic acid (HA) therapeutic products for tissue protection, healing and repair. Anika’s HA products are used in joint health therapies, , ophthalmic surgery, anti-adhesive surgical applications, and as a dermal filler in aesthetic dermatology. Found throughout the body, HA enhances joint function, protects and lubricates soft tissues and supports skin structure and elasticity.
Industry
Healthcare
Anika Therapeutics, Inc. Headquaters
32 Wiggins Avenue
Bedford,01730
United States
Anika Therapeutics, Inc. Share price
27 Jan 2021 01:06 GMT
$39.16
0.47 (1.21 %)
Anika Therapeutics, Inc. Market cap
$542.994 M
WMC RANKING
2021
Anika Therapeutics, Inc. # 57
BiotechnologyLatest Anika Therapeutics, Inc. News
25 Jan 2021
Adhesion Barriers Market Recent Study Including Growth ...
The Adhesion Barriers revenue from every top company profiled in this report is analyzed from their annual reports. ... Anika Therapeutics Inc. (U.S.) C. R. Bard ...
25 Jan 2021
Global Hyaluronic Acid (HA) Raw Material Market Research ...
Anika Therapeutics, Inc. Smith & Nephew Maruha Nichiro Corporation Ferring B.V.. SEIKAGAKU CORPORATION Genzyme Corporation Roche Contipro a.s.
25 Jan 2021
Facial Aesthetics Market Research Report Analysis And ...
The database of the company is updated on a daily basis to prompt the clients with the latest trends and in-depth analysis of the industry. Our pool of database ...
WMC Market Score
WMC Market to Revenue Score
Anika Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Anika Therapeutics, Inc. | USD | $114,610 | $51,615 | $27,193 | $5,430M | 57 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $580,590B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $353,780B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $617,950B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Anika Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Anika Therapeutics, Inc. Post vs Top 4 Industry Competitors
Anika Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Anika Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Anika Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Anika Therapeutics, Inc. | 1.24 | 2.77 | 3.79 | 0 | 0 | 0 | 3.54 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.47 | 10.77 | 100 | 0 | 0 | 93.77 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.60 | 100 | 60 | 0 | 0 | 93.49 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 3.19 | 86 | 0 | 0 | 100 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
